Compare StocksABBV vs COP

AbbVie Inc. (ABBV) vs ConocoPhillips (COP): Which Is the Better Buy in 2026?

As of 2026-08-03, ABBV is overvalued at $251, with a DCF intrinsic value of $178 and a margin of safety of -41%. COP is fairly valued at $120, with an intrinsic value of $113 and a margin of safety of -7%. Of the two, COP has the wider margin of safety.

ABBV
AbbVie Inc.
$250.94
VS
COP
ConocoPhillips
$120.48

Rewards

ABBV
  • AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Gross margin of 72.8% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
COP

    Risks

    ABBV
    • Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
    • Free cash flow has declined at a 9.8% CAGR over the past 4 years — a concerning trend.
    COP
    • ROIC has declined by 17.9 percentage points over the past 4 years, which may signal competitive erosion.
    • Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
    • Trailing P/E of 20.4x is 69% above the historical average of 12.1x — the stock trades at a premium to its own history.

    Key Valuation Metrics

    Learn more →
    ABBV
    COP
    Valuation
    N/A
    Free Cash Flow
    $7.24B
    N/A
    FCF Yield
    4.93%
    70.89
    Trailing P/E
    20.42
    15.41
    Forward P/E
    13.38
    Quality & Moat
    27.60%
    ROIC
    11.77%
    N/A
    ROE
    11.28%
    72.79%
    Gross Margin
    45.59%
    0.41
    PEG Ratio
    1.02
    Balance Sheet Safety
    N/A
    Net Debt / Equity
    0.26
    N/A
    Interest Coverage
    N/A
    2.06
    Net Debt / EBITDA
    0.73
    2.76%
    Dividend Yield
    2.79%
    ABBV: 3Ties: 2COP: 3
    ABBVCOP

    Historical Fundamentals

    Learn more →
    ABBV

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    COP

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    $1 Retained Earnings Test

    Learn more →
    ABBV
    N/A
    Net losses over 3 years — test not applicable
    Company had negative cumulative retained earnings
    Σ Retained
    $-19.85B
    Δ Market Cap
    +$118.02B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
    COP
    $-1.99
    created per $1 retained over 3 years
    Market Cap Declined
    Σ Retained
    $14.97B
    Δ Market Cap
    $-29.73B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Discounted Cash Flow (DCF) Analysis

    Learn more →
    ABBV
    40.7% Overvalued
    Price is 40.7% above estimated fair value
    Current Price: $250.94
    Fair Value: $178.31
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued
    COP
    39.4% Overvalued
    Price is 39.4% above estimated fair value
    Current Price: $120.48
    Fair Value: $86.45
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued

    Reverse DCF — Market-Implied Growth

    Learn more →
    ABBV

    Requires positive FCF to compute implied growth rate.

    COP

    What growth rate is the market pricing in at $120?

    +8.1%
    Market-Implied Owner Earnings Growth
    Standard FCF implies +9.4%

    The market implies +8.1% Owner Earnings growth, above historical trends.

    Standard FCF implies a demanding +9.4%, reflecting heavy growth investment.

    Economic Moat Score

    Learn more →
    ABBV
    82/100
    Wide Moat
    70+ Wide · 40-69 Narrow · <40 None

    Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
    COP
    38/100
    No Moat
    70+ Wide · 40-69 Narrow · <40 None

    No durable moat detected, though roic consistency shows some competitive positioning. The business lacks consistent evidence of sustainable advantages.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

    Forensic Accounting

    Learn more →
    ABBV
    -2.86
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
    COP
    -2.89
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Ownership Breakdown

    Learn more →
    ABBV
    Insiders 0.1%Institutions 76.9%Retail & Other 23.0%
    No. of Institutional Holders5,146
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
    COP
    Insiders 0.1%Institutions 87.3%Retail & Other 12.6%
    No. of Institutional Holders3,062
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

    High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

    Insider Buying Activity

    Learn more →
    ABBV
    0
    Buys (3M)
    0
    Buys (12M)
    No open market insider purchases found.
    Open market purchases · includes direct & indirect ownership · excludes option exercises
    COP
    0
    Buys (3M)
    1
    Buys (12M)
    Total value (12M): $500,000
    MCRAVEN WILLIAM H.
    Director
    $500,000
    @ $86.69 · 2025-11-10
    JOHNSON KIRK L
    Officer
    $499,472
    @ $94.24 · 2025-06-16
    MURTI ARJUN N
    Director
    $239,675
    @ $95.87 · 2024-12-20
    WALKER R A
    Director
    $1.02M
    @ $97.80 · 2024-12-17
    Open market purchases · includes direct & indirect ownership · excludes option exercises

    Open market purchases · includes direct & indirect ownership · excludes option exercises.

    Insider Selling Activity

    Learn more →
    ABBV
    0
    Sells (3M)
    0
    Sells (12M)
    No open market insider sales found.
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
    COP
    1
    Sells (3M)
    12
    Sells (12M)
    Total value (12M): $127.52M
    MULLIGAN SHARMILA
    Director
    $234,906
    @ $119.00 · 2026-06-10
    ROSE KELLY BRUNETTI
    General Counsel
    $1.00M
    @ $130.03 · 2026-03-24
    OLDS NICHOLAS G
    Officer
    $888,651
    @ $127.06 · 2026-03-23
    LANCE RYAN MICHAEL
    Chief Executive Officer
    $64.49M
    @ $127.26 · 2026-03-20
    HRAP HEATHER GRACE
    Officer
    $317,631
    @ $119.68 · 2026-03-13
    LUNDQUIST ANDREW D
    Officer
    $4.13M
    @ $119.68 · 2026-03-13
    OLDS NICHOLAS G
    Officer
    $1.73M
    @ $119.36 · 2026-03-12
    HAYNES-WELSH KONTESSA S.
    Officer
    $1.24M
    @ $120.07 · 2026-03-12
    OLDS NICHOLAS G
    Officer
    $1.41M
    @ $116.37 · 2026-03-11
    ROSE KELLY BRUNETTI
    General Counsel
    $1.00M
    @ $118.04 · 2026-03-09
    LEACH TIMOTHY ALLEN
    Director
    $4.75M
    @ $118.79 · 2026-03-06
    LANCE RYAN MICHAEL
    Chief Executive Officer
    $46.32M
    @ $92.50 · 2025-12-19
    LEACH TIMOTHY ALLEN
    Director
    $6.00M
    @ $108.11 · 2024-08-13
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

    🎭 Mr. Market's Mood

    Learn more →
    ABBV
    FearGreed
    😏Greed(61/100)

    "Market is optimistic — be cautious and ensure you have a margin of safety"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
    COP
    FearGreed
    😏Greed(61/100)

    "Market is optimistic — be cautious and ensure you have a margin of safety"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    ⚖️ Buffett Signal

    Learn more →
    ABBV
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Greed (61)
    COP
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Greed (61)
    View ABBV Full AnalysisView COP Full Analysis

    Frequently Asked Questions: ABBV vs COP

    Is AbbVie Inc. or ConocoPhillips more undervalued in 2026?

    Based on our discounted cash flow model, COP trades at a -6.6% margin of safety (intrinsic value $113 vs. price $120), compared to ABBV's -40.7% margin of safety (intrinsic $178 vs. $251).

    Which stock has a wider economic moat, AbbVie Inc. or ConocoPhillips?

    ABBV scores 82/100 (Wide moat), while COP scores 38/100 (None moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

    Is AbbVie Inc. in financial distress?

    ABBV's Altman Z-Score of 2.4 places it in the Grey zone, signaling elevated bankruptcy risk. COP scores 2.8 (Grey zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

    Which stock has higher return on invested capital, AbbVie Inc. or ConocoPhillips?

    ABBV earns 27.6% ROIC versus COP's 11.8%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

    Which dividend is safer, AbbVie Inc.'s or ConocoPhillips's?

    COP's dividend earns a safety score of 78/100 (Safe), compared to ABBV's 39/100 (Unsafe). COP has raised its dividend for 1 consecutive years.